Didier Coquoz

-International Executive with a combined expertise in drug development (from early stage up to and including registration) and biopharmaceutical companies development on both sides of the Atlantic. Executive management level.-Entrepreneurial, action-driven, problem-solving pharmaceutical professional with extensive experience in Western Europe and North America, as well as in Russia, Eastern Europe and South America. Proven ability to solve and manage complex drug and devices development/ scientific/ regulatory/ business/ marketing/ licensing issues. Demonstrated strong multicultural and multi-disciplinary leadership with excellent managerial (hiring and direct management of multicultural and multifunctional/multidisciplinary teams), conceptual, analytical, planning, and communication skills.-Professional life moto: valorize most expertises critical to pharmaceutical/medtech executives (drug and devices development, regulatory, corporate development and management, business development, financing) through executive positions in small/medium sized professional environments with international exposure.-Hands-on experience in developing, registering, and licensing worldwide of new chemical entities, peptides, recombinant drugs, antibodies, biologics and advanced drug delivery systems•development/regulatory handling of over 25 drugs/therapies/devices worldwide•development from early pre-clinical stage (translational medicine) up to and including phase III clinical studies and regulatory filing (EMA, FDA, South America (Mexico)).•realization of scientific advices, pre-IND, IND, MAA and NDA•in-licensing•positions:•CDO/Chief Regulatory Officer, Effimune SAS, Nantes, France, VII 2012 - current•CDO/Chief Regulatory Officer, Mestex AG, Zurich, Switzerland, VII 2012 – current•CDO/Chief Regulatory Officer, Biolingus, Switzerland, I 2014 - current•CDO/CBD&L, Cytune Pharma, Nantes, France, I 2011 – I 2015•Qualified Person, Smith & Nephews, Switzerland, XII 2013- IX 2014•Qualified Person, LRK/Aromasan/Oligopharm, Switzerland, I 2011 - current•Chief Regulatory Officer, Atlab Pharma, Nantes, France, VII 2011 – I 2014•Chief Regulatory Officer, Neuronax SAS, Clermont-Ferrand, France, CNS, V 2013 – XII 2013•VP R&D and partner, Triskel Integrated Services, Switzerland, X 1995- VI 2000 and IV-2009 – X 2010•Interim CEO, Oncalis AG, Switzerland, II 2008 – II 2009•CEO, Xigen S.A., Switzerland, IV 2004 – XII 2007•VP R&D, H3 PHARMA Inc., Montreal, Canada, VII 2000- III 2004•Co-founder and former chairman of the BoD Stemergie S.A., Switzerland, XII 2009 – present •President, Copexis S.A. (formerly DRDC Pharma S.A.), Switzerland, VI 1994 – present•Scientific Projects Manager, Servier, Switzerland, II 1991- VI 1995